{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T09:11:48Z","timestamp":1698829908547},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>S. Belaiche, M. Roustit, P. Bedouch, S. Quetant, C. Saint\u2010Raymond, C. Pison. Management of voriconazole hepatotoxicity in a lung transplant patient.\u2028Transpl Infect Dis 2011: <jats:bold>13:<\/jats:bold> 309\u2013311. All rights reserved<\/jats:p><jats:p><jats:bold>Abstract: <\/jats:bold> Lung allograft airway colonization by <jats:italic>Aspergillus<\/jats:italic> species is common among lung transplant recipients. We report the case of a 46\u2010year\u2010old female lung transplant outpatient diagnosed with persistent pulmonary <jats:italic>Aspergillus<\/jats:italic> colonization (&gt;50 colonies of <jats:italic>Aspergillus terreus<\/jats:italic>) 3 months after lung transplantation. Oral voriconazole 200\u2003mg twice a day (b.i.d) was initiated shortly after diagnosis. Two days after voriconazole initiation, alkaline phosphatase (ALP), alanine transaminase (ALT), and aspartate transaminase (AST) were normal or slightly elevated (79, 37, and 21\u2003UI\/L, respectively). Ten days after the first voriconazole administration, these values started to increase. Maximum levels were reached after 20 days for ALP (369\u2003UI\/L) and at around 30 days for ALT and AST (223 and 188\u2003UI\/L, respectively). Instead of discontinuing antifungal therapy, it was decided to reduce the voriconazole dose to 100\u2003mg b.i.d. This asymptomatic progressive cholestatic hepatitis resolved, and 10 days after dose reduction ALP, ALT, AST were at 136, 53, and 28\u2003UI\/L, respectively. Finally, therapeutic drug monitoring revealed adequate voriconazole plasma trough concentrations (0.98\u2003mg\/L) 30 days after dose reduction and no more colonies of <jats:italic>Aspergillus<\/jats:italic> were observed. Voriconazole\u2010induced hepatotoxicity is a well known dose\u2010dependent adverse drug reaction. This experience confirms the appropriateness of voriconazole dose reduction instead of therapy interruption in dose\u2010dependent moderate liver toxicity. Voriconazole therapeutic drug monitoring before and after dose reduction may help to avoid drug accumulation and inappropriately low drug exposure, respectively.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2010.00590.x","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T19:51:54Z","timestamp":1293047514000},"page":"309-311","source":"Crossref","is-referenced-by-count":4,"title":["Management of voriconazole hepatotoxicity in a lung transplant patient"],"prefix":"10.1111","volume":"13","author":[{"given":"S.","family":"Belaiche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roustit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bedouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Quetant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Saint\u2010Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02635.x"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200505-727SO"},{"issue":"12","key":"e_1_2_3_4_2","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain S","year":"2006","journal-title":"Am J Transplant"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl108"},{"issue":"1","key":"e_1_2_3_6_2","first-page":"125","article-title":"Voriconazole therapeutic drug monitoring","volume":"9","author":"Pasqualotto AC","year":"2010","journal-title":"focus on safety"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/525258"},{"issue":"1","key":"e_1_2_3_8_2","first-page":"2","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy","volume":"44","author":"Walsh TJ","year":"2007","journal-title":"an externally controlled trial"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/521174"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/524669"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2010.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2010.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:02:54Z","timestamp":1698778974000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2010.00590.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1399-3062.2010.00590.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00590.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}